PK studies of topical HT-001 reveal limited systemic absorption and ~99% reduced systemic levels as compared to FDA approved oral formulations. Safety and tolerability findings included: No serious ...

Given the lack of guidance in the literature regarding drug absorption after RYGB, it is important for practitioners caring for this population to be able to predict possible factors affecting drug ...